Cas:161561-83-7 boc-dap(aloc)-oh manufacturer & supplier

We serve Chemical Name:boc-dap(aloc)-oh CAS:161561-83-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

boc-dap(aloc)-oh

Chemical Name:boc-dap(aloc)-oh
CAS.NO:161561-83-7
Synonyms:L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-propen-1-yloxy)carbonyl]amino]-;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(prop-2-enoxycarbonylamino)propanoic acid;3-{[(Allyloxy)carbonyl]amino}-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-alanine
Molecular Formula:C12H20N2O6
Molecular Weight:288.297
HS Code:2924199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:470.5±45.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.488
PSA:113.96000
Exact Mass:288.132141
LogP:2.22

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-propen-1-yloxy)carbonyl]amino]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-{[(Allyloxy)carbonyl]amino}-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-alanine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-propen-1-yloxy)carbonyl]amino]- Use and application,(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(prop-2-enoxycarbonylamino)propanoic acid technical grade,usp/ep/jp grade.


Related News: In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said. boc-dap(aloc)-oh manufacturer ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. boc-dap(aloc)-oh supplier The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. boc-dap(aloc)-oh vendor The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. boc-dap(aloc)-oh factory The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.